Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIGHT-HBR: Bivalirudin vs Heparin in HBR ACS Patients Undergoing PCI
NCT07383155Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of bivalirudin in acute coronary syndrome (ACS), sponsored by General Hospital of the Northern Theater Command. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07383155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07383155.